In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting ?-catenin, a historically "undruggable" protein, in just two months. This ...

In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide ...

Scientists have visualized the detailed structure of protein clumps linked to Huntington's disease, offering critical ...

RiDYMO® has been successfully employed in various drug discovery programs, including the development of small molecule ...

When a spider is spinning its web, its silk starts out as liquid and quickly turns into a solid that is, pound for pound, ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...